FFundraiseJet
Colle Capital Partners logo

Colle Capital Partners

New York, New York · Invests in US; North America; LATAM; Europe · Website

Check size

$750K-$3M

+ Save to my list
Pre-SeedSeedSeries AB2B SaaSAI & Machine LearningDeveloper ToolsData & AnalyticsCybersecurityFintechHealthcare & Digital HealthLogistics & Supply ChainFintech & PaymentsEnterprise SoftwareDeveloper Tools & Infrastructure

Thesis

We invest in people and give them freedom and support needed to execute their vision. We rely on data to measure, manage and monetize. We encourage bold ideas which are true, firm, confident, strong and resilient. We praise agility - the key to success in a competitive environment. We invest in early-stage companies operating with clear focus on sustainability in every dimension: business practices, unit economics and environmental impact.

Likely not a fit for

We avoid consumer apps without clear data advantages, regulatory-light businesses in non-critical sectors, solo founders without operational experience, companies with poor unit economics or sustainability profiles, and highly speculative deep tech without clear market path.

How they invest

Lead or follow
Leads or follows
Typical decision
~2 weeks
Warm intro
Not required
Involvement
Takes a board seat
Fund status
Actively deploying
Decision process
Partnership vote

Partners & team

5 contacts on file

VG

Victoria Grace

Founding Partner · Primary contact

CM

Cheryl Martin

Partner

DB

Doug Benowitz

Principal

LF

Lone Fønss Schrøder

Venture Partner

KL

Kevin Lynch

Chief Financial Officer & Chief Compliance Officer

Portfolio

WindgapBiotech Life Sciences

Windgap Medical focuses on innovative autoinjectors for complex drug delivery, aiming to solve challenges in the drug delivery space that other companies may not address.

Vergent BioscienceBiotech Life Sciences

Vergent Bioscience is a clinical-stage biotechnology company focused on improving tumor visualization during minimally invasive and robotic-assisted cancer surgeries through its investigational imaging agent, VGT-309.

VangstHr Tech Work

Vangst makes it easy to find quality temp and temp-to-perm roles in the cannabis industry, agriculture, and light industrial sectors, combining experienced recruiters with advanced AI technology to match job seekers with employers.

SyftHr Tech Work

Syft is an app designed for temporary jobs and flexible work, providing instant access to thousands of job opportunities for jobseekers and a pre-verified workforce for employers.

Smunch
SkopeNowSecurity Cyber

Skopenow provides a comprehensive investigations platform that merges public data with AI to modernize investigations and enhance threat detection and fraud prevention.

SensydiaHealthcare Digital

Sensydia is committed to developing technology for the rapid, non-invasive diagnosis and management of patients with heart disease. Their Cardiac Performance System (CPS) enables accurate hemodynamic measurements and aims to improve patient outcomes while reducing healthcare costs.

SALIDO
RaivenEnterprise Software

Raiven simplifies sourcing through digital supply chain management, helping HVAC contractors purchase like Fortune 500 companies.

Connected Yard
PetPocketBookEnterprise Software

PetPocketbook is a pet care business software that automates billing, streamlines scheduling, and helps pet business owners manage their operations more efficiently.

OculogicaHealthcare Digital

Oculogica is an eye-tracking-based, neuro-diagnostic company that has developed the EyeBOX, the first FDA-cleared baseline-free aid in the diagnosis of concussion. The EyeBOX test is a non-invasive, four-minute assessment that provides objective data to help clinicians diagnose concussions.

Recent activity

Colle Capital Partners in the news

Similar firms

Research briefRead more
Colle Capital Partners Research Document Executive Summary Colle Capital Partners is a global, opportunistic early-stage technology venture fund headquartered in New York. With a data-obsessed investment philosophy and deep sector expertise in infrastructure for complex, regulated, and fragmented systems, Colle focuses on identifying and backing mission-driven teams that can execute with agility. The fund pairs a core team of experienced investors with a deep network of sector-specific advisors, including former Nike, Uber, and Fortune 500 executives, while embedding sustainability as a core investment criterion. Investment Thesis Colle Capital's investment philosophy is rooted in five core principles: People-First Investing - They invest in people and believe in identifying teams that demonstrate not just intellect and passion, but also agility in thinking and execution. The fund seeks organizations that can adapt quickly to market changes and pivots. Data-Obsessed Approach - Virtually all Colle portfolio deals have an intrinsic relationship with data. The fund believes that the ability to isolate, utilize, and act upon the best possible information is the foundation of success. Companies demonstrating data leverage, analytics, or information advantages are particularly attractive. Bold Ideas with Resilience - Colle seeks to back bold, original ideas that are true, firm, confident, strong and resilient. The fund looks for companies addressing real market problems with novel approaches. Operational Support from Day One - Beyond capital, Colle assists with all critical tasks young startups require. The fund brings operational expertise across multiple domains through its advisor network. Sustainability-Focused - Colle emphasizes companies operating with clear focus on sustainability across three dimensions: business practices, unit economics, and environmental impact. This is embedded in the investment criteria, not treated as a secondary consideration. Sector Focus While Colle describes itself as "opportunistic," the fund has demonstrated gravitational pulls toward three primary sectors: Logistics & Supply Chain - Infrastructure companies optimizing transportation, warehousing, and supply chain operations globally. Portfolio examples include Frete (Brazilian freight brokerage using big data), Hyliion (electrified powertrain solutions), and Connected Yard (pool care automation). Healthcare & Digital Health - Both medical devices and healthcare IT, with emphasis on technology-enabled care delivery and diagnostic innovation. Portfolio companies include Windgap (next-gen EpiPen), Sensydia (non-invasive heart monitoring), Hyperfine (point-of-care MRI), Vergent Bioscience (surgical imaging), Maven Clinic (virtual women's healthcare), and Numan (AI-powered preventive healthcare). Fintech & Payments - Financial infrastructure and fintech solutions, including Bread (BNPL solutions, acquired by Alliance Data), AZA Group (crypto-fiat payments in Africa), and Minka (open infrastructure for money in Latin America). Beyond these primary sectors, Colle has invested across enterprise software (MarketMuse, SkopeNow, Doctor.com), HR tech and recruitment (Syft, Vangst), consumer e-commerce (BlaBlaCar, MaxBone), gaming (Wagr), and manufacturing/hardware (LiquidPiston). Geographic Preferences Colle is explicitly global in scope, stating they evaluate and invest in companies worldwide. Geographic preferences include: North America (particularly US) Latin America (LATAM) Europe (multiple countries, with apparent Nordics strength given advisor base) Selective emerging markets (Africa focus with AZA Group; Asia implied through global mandate) The fund's deep advisor network, including executives from Maersk, Volvo, IKEA, and other global multinationals, supports international deal sourcing and post-investment support. Stage Focus Colle is a early-stage specialist , with primary focus on: Pre-Seed to Seed - Most common entry point Series A - Occasional participation and follow-ons Series B and beyond - Rare, usually existing portfolio follows The fund's check size range ($750K-$3M based on API data) aligns with classic early-stage positioning. Colle typically prefers to "step in early in the lifecycle of a company" and help teams achieve their goals. Check Size & Deployment Based on firm data: Minimum check size : $750,000 Maximum check size : $3,000,000 Sweet spot : Appears to be $1M-$2M range for seed rounds Lead/Follow tendency : Portfolio data suggests Colle leads rounds frequently but also participates in co-led and consortium investments The fund maintains meaningful follow-on reserves to support portfolio companies through subsequent rounds, particularly for best performers. Team & Decision-Making Core Management: Victoria Grace, Founding Partner - Deep technology M&A and venture experience. Former partner at Wall Street Technology Partners. Background spans enterprise software, medical devices, health IT, FinTech, hardware, and VR. Doug Benowitz, Principal - Early-stage sourcing and diligence specialist. Former BlackRock Investment Strategist. Lone Fønss Schrøder, Venture Partner - CEO of Concordium with 22+ years executive experience at Maersk and IKEA. Kevin Lynch, CFO & Chief Compliance Officer - 13+ years private equity CFO experience. Advisory Network : 30+ sector-specific experts including former Nike Chief Sustainability Officer, Microsoft executives, medical device innovators, and board governance experts. Investment Activity & Momentum Recent Activity (2025): Neuron Factory (Seed, May 2025) Farmers Business Network (July 2025) Portfolio companies EnsoData and Numan raising Series B rounds (November 2025) Fund Status : Actively deploying with strong capital availability Notable Track Record : 80+ investments, 25+ acquisitions, 2+ public companies (Hyliion NYSE, SWVL via SPAC) Key Investment Preferences Data leverage : Companies with proprietary datasets or information advantages Sustainability : Real focus on business practices, unit economics, and environmental impact Global reach : Ability to expand internationally Founder quality : Teams with agility, domain expertise, and operational capability Operational support : Post-investment value-add through advisor network Notable Portfolio Companies Windgap (next-gen EpiPen), Sensydia (heart monitoring), Hyperfine (point-of-care MRI), Maven Clinic (women's healthcare), Numan (preventive healthcare), Hyliion (electric powertrain), Frete (freight brokerage), Bread (BNPL, acquired Alliance Data), AZA Group (crypto-fiat payments), Minka (Latin America fintech), Syft (hospitality recruitment, acquired Indeed), Vangst (cannabis recruitment), SkopeNow (OSINT platform), Doctor.com (healthcare marketing, acquired Press Ganey), MarketMuse (content intelligence), BlaBlaCar (ridesharing) Conclusion Colle Capital Partners is a disciplined, data-obsessed early-stage fund with unique advantages in global sourcing, sector depth, and post-investment support through its advisor network. The fund's commitment to sustainability and strong operational expertise positions it well to back ambitious founders building complex, regulated, and data-intensive businesses globally.

Add Colle Capital Partners to your investor list

Sign up free to save investors, see partner contacts, and track your raise.

Sign up